Alivus Life Sciences Limited — Board Meeting, 01-08-2025: Outcome of Board Meeting

Alivus Life Sciences has released its Q1 FY26 financial results! The company saw strong performance with revenue from operations hitting ₹601.85 Cr for the quarter ended June 30, 2025. This is a solid increase from ₹588.62 Cr in the same quarter last year. Net profit for the period also jumped to ₹121.54 Cr, up from ₹111.48 Cr. Basic earnings per share (EPS) stood at ₹9.91. A positive start to the financial year! #AlivusLifeSciences #Q1Results #API